A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback